These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 26536290)

  • 1. Quality assurance of metabolomics.
    Bouhifd M; Beger R; Flynn T; Guo L; Harris G; Hogberg H; Kaddurah-Daouk R; Kamp H; Kleensang A; Maertens A; Odwin-DaCosta S; Pamies D; Robertson D; Smirnova L; Sun J; Zhao L; Hartung T
    ALTEX; 2015; 32(4):319-26. PubMed ID: 26536290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: toxicometabolomics.
    Bouhifd M; Hartung T; Hogberg HT; Kleensang A; Zhao L
    J Appl Toxicol; 2013 Dec; 33(12):1365-83. PubMed ID: 23722930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics 2023 workshop report: moving toward consensus on best QA/QC practices in LC-MS-based untargeted metabolomics.
    Mosley JD; Dunn WB; Kuligowski J; Lewis MR; Monge ME; Ulmer Holland C; Vuckovic D; Zanetti KA; Schock TB;
    Metabolomics; 2024 Jul; 20(4):73. PubMed ID: 38980450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human toxome project.
    Bouhifd M; Andersen ME; Baghdikian C; Boekelheide K; Crofton KM; Fornace AJ; Kleensang A; Li H; Livi C; Maertens A; McMullen PD; Rosenberg M; Thomas R; Vantangoli M; Yager JD; Zhao L; Hartung T
    ALTEX; 2015; 32(2):112-24. PubMed ID: 25742299
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Framework for the quality assurance of 'omics technologies considering GLP requirements.
    Kauffmann HM; Kamp H; Fuchs R; Chorley BN; Deferme L; Ebbels T; Hackermüller J; Perdichizzi S; Poole A; Sauer UG; Tollefsen KE; Tralau T; Yauk C; van Ravenzwaay B
    Regul Toxicol Pharmacol; 2017 Dec; 91 Suppl 1(Suppl 1):S27-S35. PubMed ID: 28987912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Importance of Experimental Design, Quality Assurance, and Control in Plant Metabolomics Experiments.
    Martins MCM; Caldana C; Wolf LD; de Abreu LGF
    Methods Mol Biol; 2018; 1778():3-17. PubMed ID: 29761427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners.
    Evans AM; O'Donovan C; Playdon M; Beecher C; Beger RD; Bowden JA; Broadhurst D; Clish CB; Dasari S; Dunn WB; Griffin JL; Hartung T; Hsu PC; Huan T; Jans J; Jones CM; Kachman M; Kleensang A; Lewis MR; Monge ME; Mosley JD; Taylor E; Tayyari F; Theodoridis G; Torta F; Ubhi BK; Vuckovic D;
    Metabolomics; 2020 Oct; 16(10):113. PubMed ID: 33044703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards quality assurance and quality control in untargeted metabolomics studies.
    Beger RD; Dunn WB; Bandukwala A; Bethan B; Broadhurst D; Clish CB; Dasari S; Derr L; Evans A; Fischer S; Flynn T; Hartung T; Herrington D; Higashi R; Hsu PC; Jones C; Kachman M; Karuso H; Kruppa G; Lippa K; Maruvada P; Mosley J; Ntai I; O'Donovan C; Playdon M; Raftery D; Shaughnessy D; Souza A; Spaeder T; Spalholz B; Tayyari F; Ubhi B; Verma M; Walk T; Wilson I; Witkin K; Bearden DW; Zanetti KA
    Metabolomics; 2019 Jan; 15(1):4. PubMed ID: 30830465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality assurance procedures for mass spectrometry untargeted metabolomics. a review.
    Dudzik D; Barbas-Bernardos C; García A; Barbas C
    J Pharm Biomed Anal; 2018 Jan; 147():149-173. PubMed ID: 28823764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolomic network analysis of estrogen-stimulated MCF-7 cells: a comparison of overrepresentation analysis, quantitative enrichment analysis and pathway analysis versus metabolite network analysis.
    Maertens A; Bouhifd M; Zhao L; Odwin-DaCosta S; Kleensang A; Yager JD; Hartung T
    Arch Toxicol; 2017 Jan; 91(1):217-230. PubMed ID: 27039105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A perspective on the standards describing mass spectrometry-based metabolic phenotyping (metabolomics/metabonomics) studies in publications.
    Wilson ID; Theodoridis G; Virgiliou C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122515. PubMed ID: 33460910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC).
    Lippa KA; Aristizabal-Henao JJ; Beger RD; Bowden JA; Broeckling C; Beecher C; Clay Davis W; Dunn WB; Flores R; Goodacre R; Gouveia GJ; Harms AC; Hartung T; Jones CM; Lewis MR; Ntai I; Percy AJ; Raftery D; Schock TB; Sun J; Theodoridis G; Tayyari F; Torta F; Ulmer CZ; Wilson I; Ubhi BK
    Metabolomics; 2022 Apr; 18(4):24. PubMed ID: 35397018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mass spectrometry-based holistic analytical approaches for metabolite profiling in systems biology studies.
    Theodoridis G; Gika HG; Wilson ID
    Mass Spectrom Rev; 2011; 30(5):884-906. PubMed ID: 21384411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mass Spectrometry-Based Zebrafish Toxicometabolomics: A Review of Analytical and Data Quality Challenges.
    da Silva KM; Iturrospe E; Bars C; Knapen D; Van Cruchten S; Covaci A; van Nuijs ALN
    Metabolites; 2021 Sep; 11(9):. PubMed ID: 34564451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations and Standardization of Biomarker Quantification Using NMR-Based Metabolomics with Particular Focus on Urinary Analysis.
    Emwas AH; Roy R; McKay RT; Ryan D; Brennan L; Tenori L; Luchinat C; Gao X; Zeri AC; Gowda GA; Raftery D; Steinbeck C; Salek RM; Wishart DS
    J Proteome Res; 2016 Feb; 15(2):360-73. PubMed ID: 26745651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management.
    Kirwan JA; Gika H; Beger RD; Bearden D; Dunn WB; Goodacre R; Theodoridis G; Witting M; Yu LR; Wilson ID;
    Metabolomics; 2022 Aug; 18(9):70. PubMed ID: 36029375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statistical methods in metabolomics.
    Korman A; Oh A; Raskind A; Banks D
    Methods Mol Biol; 2012; 856():381-413. PubMed ID: 22399468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do we need a "Chair of alternative methods", and where?
    Wendel A
    ALTEX; 2002; 19(2):64-8. PubMed ID: 12098011
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.